Lysophosphatidic acid (LPA)‐induced vasodilator‐stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC‐3 prostate cancer cells

Prostate cancer remains the most frequently diagnosed malignancy and the second leading cause of cancer mortality among men in the United States. Hormone refractory, metastatic disease has no molecular therapeutics to date and survival is poor. Lysophosphatidic acid (LPA) is a bioactive lipid exhibi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Hasegawa, Yutaka, Murph, Mandi, Yu, Shuangxing, Tigyi, Gabor, Mills, Gordon B.
Format: Artigo
Sprache:Inglês
Veröffentlicht: John Wiley and Sons Inc. 2008
Schlagworte:
Papers
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2597858/
https://ncbi.nlm.nih.gov/pubmed/19081821
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2008.03.009
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge